Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
2.600
-0.240 (-8.45%)
At close: Mar 28, 2024, 1:10 PM
2.850
+0.250 (9.62%)
After-hours: Mar 28, 2024, 7:53 PM EDT

Finch Therapeutics Group Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
25.1271.04133.4899.7142.19
Cash & Cash Equivalents
25.1271.04133.4899.7142.19
Cash Growth
-64.63%-46.78%33.87%136.36%-
Receivables
00.140.491.14.75
Other Current Assets
0.723.378.585.361.69
Total Current Assets
25.8574.55142.55106.1648.63
Property, Plant & Equipment
27.1848.6924.6973.78
Long-Term Investments
2.352.772.2700
Goodwill and Intangibles
0018.0618.0618.06
Other Long-Term Assets
036.9337.8134.1133.11
Total Long-Term Assets
29.5388.3982.8259.1754.94
Total Assets
55.37162.94225.37165.34103.57
Accounts Payable
0.141.13.742.890.99
Deferred Revenue
00013.6310.67
Current Debt
1.723.431.1300
Other Current Liabilities
2.2210.169.93-5.03-4.33
Total Current Liabilities
4.0814.6914.7911.497.33
Long-Term Debt
28.448.914.891.810
Other Long-Term Liabilities
03.633.4714.7112.63
Total Long-Term Liabilities
28.452.548.3616.5212.63
Total Liabilities
32.4967.2323.152819.95
Total Debt
30.1352.346.021.810
Debt Growth
-42.44%770.14%232.69%--
Retained Earnings
-350.4-275.64-161-102.84-63.49
Shareholders' Equity
22.8995.71202.22-95.72-59.54
Net Cash / Debt
-518.7127.4797.942.19
Net Cash / Debt Growth
--85.33%30.20%132.07%-
Net Cash Per Share
-3.1211.7697.55360.61173.47
Working Capital
21.7659.86127.7694.6841.3
Book Value Per Share
14.2660.21154.76-352.56-244.81
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).